BCL9 and Miyoshi myopathy: It has been shown that this is the result of an interaction between MM cells and bone marrow mesenchymal stromal cells (BMSCs), which in turn increases the expression of BCL9, a transcriptional co-activator of the Wnt signaling pathway known to promote MM cell proliferation, survival, migration, and drug resistance [47].